Integration to pathways that signal cardiac growth with modulation of myofilament activity

Journal of Nuclear Cardiology

Volumn 9, Issue 5, 2002, Pages 523-533

  Solaro, R John ^a   Montgomery, David M ^a   Wang, Lynn ^a   Burkart, Eileen M ^a   Ke, Yunbo ^a   Vahebi, Susan ^a   Buttrick, Peter ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATASE; CALCINEURIN; CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; LY 379196; MITOGEN ACTIVATED PROTEIN KINASE; MUSCLE PROTEIN; MYOSIN BINDING PROTEIN C; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C BETA; PROTEIN KINASE C INHIBITOR; PROTEIN P21; RHO FACTOR; RHO KINASE; SYNAPTOPHYSIN; TROPOMYOSIN; TROPONIN I; TROPONIN T;

CELL ACTIVITY; CELL FUNCTION; CELL GROWTH; CELL NUCLEUS; EXCITATION CONTRACTION COUPLING; GENE MUTATION; GENETIC LINKAGE; HEART DEVELOPMENT; HEART FAILURE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LINKAGE ANALYSIS; MYOFILAMENT; PRIORITY JOURNAL; REVIEW; SARCOMERE; SIGNAL TRANSDUCTION; TREATMENT PLANNING;

EID: 0036765578     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2002.127626     Document Type: Review

References (69)

1. 2+. Heart Failure 1994;10:150-5.
2. 2+: implications of mutations causal for familial hypertrophic cardiomyopathy. Basic Res Cardiol 1997;92(Suppl I):63-74.
3. Molkentin JD, Dorn GW II. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 2001;63:391-426.
4. de Tombe PP, Solaro RJ. Integration of cardiac myofilament activity and regulation with pathways signaling hypertrophy and failure. Ann Biomed Eng 2000;28:991-1001.
5. Solaro RJ. Modulation of cardiac myofilament activity by protein phosphorylation. Handbook of physiology, section 2: the cardiovascular system, vol 1: the heart. In: Page E, Fozzard HA, Solaro RJ, eds. New York: Oxford University Press; 2002. p. 264-300.
6. Squire JM, Morris EP. A new look at thin filament regulation in vertebrate skeletal muscle. FASEB J 1998;12:761-71.
7. Takeda S, Yamashita A, Maeda K, Maeda Y. Crystal structure of troponin ternary complex [abstract]. Biophys J 2002;82:170a.
8. Pan B-S, Solaro RJ. Calcium binding properties of troponin C in detergent skinned heart muscle fibers. J Biol Chem 1987;262: 7339-49.
9. 2+-regulatory site of bovine cardiac troponin. J Biol Chem 1982;257:260-3.
10. Spyracopoulos L, Li MX, Sia SK, Gagne SM, Chandra M, Solaro RJ, et al. Calcium-induced structural transition in the regulatory domain of human cardiac troponin C. Biochemistry 1997;36:12138-46.
11. Dong WJ, Xing J, Villain M, Hellinger M, Robinson JM, Chandra M, et al. Conformation of the regulatory domain of cardiac muscle troponin C in its complex with cardiac troponin I. J Biol Chem 1999;274:31382-90.
12. Li MX, Spyracopoulos L, Sykes BD. Binding of cardiac troponin-I147-163 induces a structural opening in human cardiac troponin-C. Biochemistry 1999;38:8289-98.
13. Moss RL, Buck SH. Regulation of cardiac contraction by calcium. Handbook of physiology, section 2: the cardiovascular system, vol 1: the heart. In: Page E, Fozzard H, Solaro RJ, eds. New York: Oxford University Press; 2002. p. 420-54.
14. Fuchs F, Smith SH. Calcium, cross-bridges, and the Frank-Starling relationship. News Physiol Sci 2001;16:5-10.
15. Solaro RJ, Rarick HM. Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments. Circ Res 1998;83:471-80.
16. 2+-sensitive isoforms in the failing human heart. Circulation 1999;99:384-91.
17. Bowman JC, Steinberg SF, Jiang T, Geenen DL, Fishman GI, Buttrick PM. Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates. J Clin Invest 1997;100:2189-95.
18. (2+) transients of mouse heart myocytes conditionally expressing PKCbeta. Am J Physiol Cell Physiol 2001;280:C1114-20.
19. (2+) current from neonatal mouse ventricular myocytes by constitutively active PKC-betaII. Am J Physiol Cell Physiol 2002;282:C768-74.
20. Takeishi Y, Chu G, Kirkpatrick DM, Li Z, Wakasaki H, Kranias EG, et al. In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts. J Clin Invest 1998;102:72-8.
21. Takeishi Y, Ping P, Bolli R, Kirkpatrick DL, Hoit BD, Walsh RA. Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy. Circ Res 2000;86:1218-23.
22. (2+)-stimulated MgATPase of reconstituted actomyosin S-1. J Biol Chem 1995;270:25445-54.
23. Montgomery DE, Chandra M, Huang Q-Q, Jin J-P, Solaro RJ. Transgenic incorporation of fast skeletal troponin T into cardiac myofilaments blunts PKC-mediated depression of force. Am J Physiol Heart Circ, Physiol 2001;280:H1011-8.
24. Montgomery DE, Wolska BM, Pyle WG, Roman BB, Dowell JC, Buttrick PM, et al. α-Adrenergic response and myofilament activity in mouse hearts lacking PKC-specific phosphorylation sites on troponin I. Am J Physiol Heart Circ Physiol 2002;282:H2397-405.
25. MacGowan GA, Du C, Cowan DB, Stamm C, McGowan FX, Solaro RJ, et al. Ischemic dysfunction in transgenic mice expressing troponin I lacking protein kinase C phosphorylation sites. Am J Physiol Heart Circ Physiol 2001;280:H835-43.
26. Gupta MP, Gupta M, Jakovcic S, Zak R. Catecholamines and cardiac growth. Mol Cell Biochem 1996;163-164:203-10.
27. i-proteins in heart failure. Lancet 1988;2:936-7.
28. Feldman AM, Cates AE, Bristow MR, Van Dop C. Altered expression of alpha-subunits of G proteins in failing human hearts. J Mol Cell Cardiol 1989;21:359-65.
29. Fentzke RC, Buck SH, Patel JR, Lin H, Wolska BM, Stojanovic MO, et al. Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart. J Physiol (London) 1999;517:143-57.
30. Zakhary DR, Moravec CS, Bond M. Regulation of PKA binding to AKAPs in the heart: alterations in human heart failure. Circulation 2000;101:1459-64.
31. Wolff MR, Buck SH, Stoker SW, Greaser ML, Mentzer RM. Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation. J Clin Invest 1996;98:167-76.
32. Sah VP, Minamisawa S, Tam SP, Wu TH, Dorn GW II, Ross J Jr, et al. Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure. J Clin Invest 1999;103:1627-34.
33. 2+ sensitivity in failing hearts. Am J Physiol Heart Circ Physiol 2001;281:H637-46.
34. Hoshijima M, Sah VP, Wang Y, Chien KR, Brown JH. The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes. Involvement of Rho kinase. J Biol Chem 1998;273:7725-30.
35. Ueyama T, Sakoda T, Kawashima S, Hiraoka E, Hirata K, Akita H, et al. Activated RhoA stimulates c-fos gene expression in myocardial cells. Circ Res 1997;81:672-8.
36. Aikawa R, Komuro I, Nagai R, Yazaki Y. Rho plays an important role in angiotensin II-induced hypertrophic responses in cardiac myocytes. Mol Cell Biochem 2000;212:177-82.
37. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Zhu W, et al. Rho family small G proteins play critical roles in mechanical stress-induced hypertrophic responses in cardiac myocytes. Circ Res 1999;84:458-66.
38. Aikawa R, Nagai T, Tanaka M, Zou Y, Ishihara T, Takano H, et al. Reactive oxygen species in mechanical stress-induced cardiac hypertrophy. Biochem Biophys Res Commun 2001;289:901-7.
39. Seasholtz TM, Majumdar M, Brown JH. Rho as a mediator of G protein-coupled receptor signaling. Mol Pharmacol 1999;55:949-56.
40. Aoki H, Izumo S, Sadoshima J. Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation. Circ Res 1998;82:666-76.
41. 13. Science 1998;280:2109-11.
42. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 2000;522:177-85.
43. Souchet M, Portales-Casamar E, Mazurais D, Schmidt S, Leger I, Javre JL, et al. Human p63RhoGEF, a novel RhoA-specific guanine nucleotide exchange factor, is localized in cardiac sarcomere. J Cell Sci 2002;115:629-40.
44. Damron DS, Darvish A, Murphy L, Sweet W, Moravec CS, Bond M. Arachidonic acid-dependent phosphorylation of troponin I and myosin light chain 2 in cardiac myocytes. Circ Res 1995;76:1011-9.
45. Kaibuchi K, Kuroda S, Amano M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 1999;68:459-86.
46. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 1996;271: 20246-9.
47. Manser E, Lim L. Roles of PAK family kinases. Prog Mol Subcell Biol 1999;399:384-8.
48. Sanders LC, Matsumura F, Bokoch GM, de Lanerolle P. Inhibition of myosin light chain kinase by p21-activated kinase. Science 1999;283:2028-9.
49. (2+) sensitivity of smooth muscle contraction. J Biol Chem 2000;275:1959-65.
50. 2+-independent contraction of smooth muscle. J Biol Chem 1998;273:23433-9.
51. Li MX, Want X, Buscemi N, Van Eyk JE, Sykes BD. Novel phosphorylation of Set 149 in cardiac troponin I (cTnI) by PAK reduces the affinity of cTnI for cardiac troponin C (cTnC) [abstract]. Biophys J 2002;82:389a.
52. Sugden PH, Clerk A. Cellular mechanisms of cardiac hypertrophy. J Mol Med 1998;76:725-46.
53. Cook SA, Sugden PH, Clerk A. Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease. J Mol Cell Cardiol 1999;31:1429-34.
54. Liao P, Georgakopoulos D, Kovacs A, Zheng M, Lerner D, Pu H, et al. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc Natl Acad Sci U S A 2001;98:12283-8.
55. Liao P, Wang SQ, Wang S, Zheng M, Zheng M, Zhang SJ, et al. p38 Mitogen-activated protein kinase mediates a negative inotropic effect in cardiac myocytes. Circ Res 2002;90:190-6.
56. (2+)-ATPase in a rat model of heart failure. Circulation 2001; 104:1424-9.
57. (2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. J Clin Invest 2000;106:1351-9.
58. Frey N, McKinsey TA, Olson EN. Decoding calcium signals involved in cardiac growth and function. Nat Med 2000;6: 1221-7.
59. 2+/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity. J Biol Chem 2002; 277:1261-7.
60. MacDougall LK, Jones LR, Cohen P. Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur J Biochem 1991;196: 725-34.
61. Luss H, Klein-Wiele O, Boknik P, Herzig S, Knapp J, Linck B, et al. Regional expression of protein phosphatase type 1 and 2A catalytic subunit isoforms in the human heart. J Mol Cell Cardiol 2000;32:2349-59.
62. Chu Y, Wilson SE, Schlender KK. A latent form of protein phosphatase 1 alpha associated with bovine heart myofibrils. Biochim Biophys Acta 1994;1208:45-54.
63. Hartshorne DJ, Ito M, Erdodi F. Myosin light chain phosphatase: subunit composition, interactions and regulation. J Muscle Res Cell Motil 1998;19:325-41.
64. Nishio H, Ichikawa K, Hartshorne DJ. Evidence for myosin-binding phosphatase in heart myofibrils. Biochem Biophys Res Commun 1997;236:570-75.
65. Westphal RS, Coffee RL Jr, Marotta A, Pelech SL, Wadzinski BE. Identification of kinase-phosphatase signaling modules composed of p70 S6 kinase-protein phosphatase 2A (PP2A) and p21-activated kinase-PP2A. J Biol Chem 1999;274:687-92.
66. Neumann J, Eschenhagen T, Jones LR, Linck B, Schmitz W, Scholz H, et al. Increased expression of cardiac phosphatases in patients with end-stage heart failure. J Mol Cell Cardiol 1997; 29:265-72.
67. (2+) uptake in human failing left ventricular myocardium. J Heart Lung Transplant 2002;21:366-73.
68. 2+ channel currents in cardiac hypertrophy induced by activation of calcineurin-dependent pathway. J Mol Cell Cardiol 2001;33:249-59.
69. Communal C, Sumandea M, de Tombe P, Narula J, Solaro RJ, Hajjar RJ. Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci U S A 2002;99:6252-6.